Skip to main content

Advertisement

Table 7 Incremental cost effectiveness analysis of chronic hepatitis B treatments

From: Cost-effectiveness analysis of oral anti-viral drugs used for treatment of chronic hepatitis B in Turkey

Treatments Total cost (TL) YLL Cost difference (TL) Year difference ICER
TDF 119,604 2.06    
ETV-TDF 161,642 2.13 42,037 0.07 Dominated
ETV 162,115 2.13 42,511 0.07 Dominated
LdT-TDF 138,182 3.05 18,577 0.99 Dominated
3TC-TDF 132,157 3.20 12,552 1.14 Dominated
LdT 151,059 4.10 31,455 2.04 Dominated
3TC 147,245 6.52 27,640 4.56 Dominated
  1. Calculations were done according to the constructed 40-year treatment model